非酒精性脂肪性肝病与冠状动脉易损斑块的关系研究

doi:10.12114/j.issn.1007-9572.2018.31.010

摘要/Abstract

摘要： 目的　探讨非酒精性脂肪性肝病（NAFLD）是否是冠状动脉易损斑块的高危人群。方法　连续纳入2011-01-01至2015-01-30四川省内江市第一人民医院住院期间曾行冠状动脉CT造影并且3个月内曾行腹部CT的患者，记录基线资料、临床诊断，根据病史及影像学指标分为NAFLD组与非NAFLD组，根据2016美国冠状动脉CT专家共识分析冠状动脉，判断有无易损斑块，记录易损斑块的数量和狭窄评分。结果　纳入本研究的患者有603例，其中NAFLD组124例，非NAFLD组479例，185（30.7%）例患者冠状动脉CT造影有易损斑块。NAFLD组易损斑块的比例高于非NAFLD组（46.0%比26.7%，P<0.001）；NAFLD组有≥2个易损斑块的患者比例高于非NAFLD组（12.9%比5.4%，P=0.004）；NAFLD组狭窄≥50%的易损斑块比例高于非NAFLD组（29.0%比13.6%，P<0.001）。多因素Logistic回归分析结果显示NAFLD是冠状动脉易损斑块的危险因素〔OR（95%CI）=2.12（1.37，3.26），P=0.001）〕。结论　NAFLD患者是冠状动脉易损斑块的高危人群。

关键词: 冠状动脉疾病, 非酒精性脂肪性肝病, 易损斑块, 冠状动脉CT造影

Abstract: Objective　To determine whether nonalcoholic fatty liver disease （NAFLD） patients are at high risk of vulnerable coronary artery plaques.Methods　We enrolled the consecutive inpatients who underwent coronary artery CT angiography （CCTA） and abdominal CT （within 3 months before or after CCTA） in the First People's Hospital of Neijiang from January 1，2011 to January 30，2015.We collected their baseline and clinical data （including diagnosis and imaging results） and divided them into NAFLD and non-NAFLD groups according to the medical history and imaging findings.We performed an analysis of the CCTA results based on CAD-RADS（an expert consensus document issued by SCCT，ACR and NASCI in 2016）.Vulnerable plaques were determined，counted and recorded，and the CAD-RADS score was recorded.Results　Totals of 603 cases were included in the study，including 124 with NAFLD and 479 without.185 （30.7% of the total） presented vulnerable plaques in CCTA.Compared with non-NAFLD patients，NAFLD patients had a higher prevalence of vulnerable plaques（46.0% vs 26.7%，P<0.001），and a higher prevalence of multiple（≥2） vulnerable plaques （12.9% vs 5.4%，P=0.004），as well as a higher prevalence of carotid stenosis of ≥50% （caused by vulnerable plaques）（29.0% vs 13.6%，P<0.001）.Multivariate Logistic regression analysis suggested that NAFLD is a risk factor for vulnerable coronary artery plaques 〔OR（95%CI）=2.12（1.37，3.26），P=0.001）〕.Conclusion　NAFLD patients are a high-risk group for vulnerable coronary artery plaques.

Key words: Coronary artery disease, Nonalcoholic fatty liver disease, Vulnerable plaque, Coronary CT angiography

杨小艳,杨勇,张旭,等. 非酒精性脂肪性肝病与冠状动脉易损斑块的关系研究[J]. 中国全科医学, 2018, 21(31): 3827-3831. DOI: 10.12114/j.issn.1007-9572.2018.31.010.
YANG Xiaoyan,YANG Yong,ZHANG Xu, et al. Relationship between Nonalcoholic Fatty Liver Disease and Vulnerable Coronary Artery Plaques[J]. Chinese General Practice, 2018, 21(31): 3827-3831. DOI: 10.12114/j.issn.1007-9572.2018.31.010.

参考文献

［1］WONG V W，CHU W C，WONG G L，et al．Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese：a population study using proton-magnetic resonance spectroscopy and transient elastography［J］．Gut，2012，61（3）：409-415.
［2］MIN J K，SHAW L J，DEVEREUX R B，et al．Prognostic value of multidetector coronary computed tomographic angiography for prediction of all-cause mortality［J］．J Am Coll Cardiol，2007，50（12）：1161-1170.
［3］MCGOVERN P G，PANKOW J S，SHAHAR E，et al．Recent trends in acute coronary heart disease：mortality，morbidity，medical care，and risk factors.The Minnesota Heart Survey Investigators［J］．N Engl J Med，1996，334（14）：884-890.
［4］温静．心电图aVR导联ST段抬高对急性冠脉综合征患者长期预后的评估价值研究［J］．实用心脑肺血管病杂志，2016，24（5）：31-34．DOI：10.3969/j.issn.1008-5971.2016.05.007.
WEN J．Role of lead aVR ST-segment elevation of ECG in the prediction of long-term prognosis of patients with acute coronary syndrome［J］．Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease，2016，24 （5）：31-34．DOI：10.3969/j.issn.1008-5971.2016.05.007.
［5］PFLEDERER T，MARWAN M，SCHEPIS T，et al．Characterization of culprit lesions in acute coronary syndromes using coronary dual-source CT angiography［J］．Atherosclerosis，2010，211（2）：437-444.
［6］PUNDZIUTE G，SCHUIJF J D，JUKEMA J W，et al．Evaluation of plaque characteristics in acute coronary syndromes：non-invasive assessment with multi-slice computed tomography and invasive evaluation with intravascular ultrasound radiofrequency data analysis［J］．European Heart Journal，2008，29（19）：2373-2381.
［7］SATO A，OHIGASHI H，NOZATO T，et al．Coronary artery spatial distribution，morphology，and composition of nonculprit coronary plaques by 64-slice computed tomographic angiography in patients with acute myocardial infarction［J］．The American Journal of Cardiology，2010，105（7）：930-935.
［8］YANG X，GAI L，DONG W，et al．Characterization of culprit lesions in acute coronary syndromes compared with stable angina pectoris by dual-source computed tomography［J］．The International Journal of Cardiovascular Imaging，2013，29（4）：945-953.
［9］HOFFMANN U，MOSELEWSKI F，NIEMAN K，et al．Noninvasive assessment of plaque morphology and composition in culprit and stable lesions in acute coronary syndrome and stable lesions in stable angina by multidetector computed tomography［J］．Journal of the American College of Cardiology，2006，47（8）：1655-1662.
［10］葛均波，徐永健.内科学［M］．8版.北京：人民卫生出版社，2013：409.
［11］CURY R C，ABBARA S，ACHENBACH S，et al．CAD-RADSTM coronary artery disease–reporting and data system.An expert consensus document of the Society of Cardiovascular Computed Tomography （SCCT），the American College of Radiology （ACR） and the North American Society for Cardiovascular Imaging （NASCI）．Endorsed by the American College of Cardiology［J］．Journal of Cardiovascular Computed Tomography，2016，10（4）：269-281.
［12］PUCHNER S B，LIU T，MAYRHOFER T，et al．High-risk plaque detected on coronary CT angiography predicts acute coronary syndromes independent of significant stenosis in acute chest pain［J］．Journal of the American College of Cardiology，2014，64（7）：684-692.
［13］MOTOYAMA S，SARAI M，HARIGAYA H，et al．Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome［J］．J Am Coll Cardiol，2009，54（1）：49-57.
［14］MOTOYAMA S，ITO H，SARAI M，et al．Plaque characterization by coronary computed tomography angiography and the likelihood of acute coronary events in mid-term follow-up［J］．J Am Coll Cardiol，2015，66（4）：337-346.
［15］MOTOYAMA S，KONDO T，SARAI M，et al．Multislice computed tomographic characteristics of coronary lesions in acute coronary syndromes［J］．J Am Coll Cardiol，2007，50（4）：319-326.
［16］INOUE K，MOTOYAMA S，SARAI M，et al．Serial coronary CT angiography-verified changes in plaque characteristics as an end point［J］．JACC：Cardiovascular Imaging，2010，3（7）：691-698.
［17］OTSUKA K，FUKUDA S，TANAKA A，et al．Napkin-ring sign on coronary CT angiography for the prediction of acute coronary syndrome［J］．JACC Cardiovasc Imaging，2013，6（4）：448-457.
［18］ONI E T，AGATSTON A S，BLAHA M J，et al．A systematic review：burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver；should we care?［J］．Atherosclerosis，2013，230（2）：258-267.
［19］KIM D，CHOI S Y，PARK E H，et al．Nonalcoholic fatty liver disease is associated with coronary artery calcification［J］．Hepatology，2012，56（2）：605-613.
［20］LABRECQUE D R，ABBAS Z，ANANIA F，et al．World Gastroenterology Organisation global guidelines：nonalcoholic fatty liver disease and nonalcoholic steatohepatitis［J］．J Clin Gastroenterol，2014，48（6）：467-473.
［21］ARBAB-ZADEH A，NAKANO M，VIRMANI R，et al．Acute coronary events［J］．Circulation，2012，125（9）：1147-1156.
［22］OSAWA K，MIYOSHI T，YAMAUCHI K，et al．Nonalcoholic hepatic steatosis is a strong predictor of high-risk coronary-artery plaques as determined by multidetector CT［J］．PLoS One，2015，10（6）：e131138.
［23］PUCHNER S B，LU M T，MAYRHOFER T，et al．High-risk coronary plaque at coronary CT angiography is associated with nonalcoholic fatty liver disease，independent of coronary plaque and stenosis burden：results from the ROMICATⅡtrial［J］．Radiology，2015，274（3）：693-701.
［24］AKABAME S，HAMAGUCHI M，TOMIYASU K，et al．Evaluation of vulnerable coronary plaques and non-alcoholic fatty liver disease （NAFLD） by 64-detector multislice computed tomography （MSCT）［J］．Circ J，2008，72（4）：618-625.

[1]	赵玉晴, 王伟, 陈立沅, 油惠娟, 魏莹, 王清路, 杨风英. 肝脏巨噬细胞极化：运动防治非酒精性脂肪性肝病的新靶向[J]. 中国全科医学, 2025, 28(27): 3456-3465.
[2]	张全爱, 李沙, 王恺悌, 董慧聪, 卢晓飞, 郭永泽. 司美格鲁肽在蛋氨酸胆碱缺乏饮食诱导的非酒精性脂肪性肝病大鼠肝脏脂质代谢中的研究[J]. 中国全科医学, 2025, 28(20): 2538-2545.
[3]	倪雪桐, 阿合叶尔克·哈冷别克, 汤建敏, 曹腾瑞, 陶丽新, 郑德强, 李强, 韩玉梅, 杨兴华. 血糖异常与非酒精性脂肪肝病的双向因果关联研究：基于北京市健康管理队列[J]. 中国全科医学, 2025, 28(13): 1607-1613.
[4]	卓莉莉, 瞿欢佳, 张秋玲. 2型糖尿病与肥胖对纤维化4指数筛查非酒精性脂肪性肝病早期肝纤维化影响的研究[J]. 中国全科医学, 2025, 28(11): 1354-1360.
[5]	曾佳玲, 蒙艳, 邓婷婷, 李锦华, 赵萍. 2型糖尿病患者非酒精性脂肪肝与内脏脂肪面积及甲状腺结节的相关性研究[J]. 中国全科医学, 2025, 28(09): 1072-1083.
[6]	王瑞, 欧阳丽娜, 吴倩, 牛媛媛, 李贵兰, 朱力. CT衍生的血流储备分数对梗阻性冠状动脉疾病患者主要不良心血管事件的预测价值研究[J]. 中国全科医学, 2025, 28(06): 713-719.
[7]	许耀珑, 赵佳欣, 杨立刚. 非酒精性脂肪性肝病流行现状及危险因素研究进展[J]. 中国全科医学, 2024, 27(30): 3825-3834.
[8]	付伟, 程国彬, 吕麟亚, 丁瑶, 王瑶, 赵俊龙. 中国汉族成年人群单不饱和脂肪酸摄入量与非酒精性脂肪性肝病风险关系的回顾性病例对照研究[J]. 中国全科医学, 2024, 27(29): 3623-3628.
[9]	胡一帆, 陈妙洋, 熊清芳, 钟艳丹, 刘杜先, 顾爱东, 杨永峰. 影像学和组织学诊断胆石症合并非酒精性脂肪性肝病的一致性研究[J]. 中国全科医学, 2024, 27(28): 3546-3551.
[10]	和军辉, 万大国, 董静, 张娟. 泛免疫炎症值、全身免疫炎症指数与急性冠脉综合征患者易损斑块的相关性研究[J]. 中国全科医学, 2024, 27(24): 2976-2981.
[11]	侯娜娜, 冯金章, 刘锁红, 冯俊芳, 薛小艳, 尹娜, 迟戈夫. 血尿酸/肌酐比值与代谢相关脂肪性肝病的相关性研究[J]. 中国全科医学, 2024, 27(20): 2476-2482.
[12]	薛亚男, 欧敏行, 张秀杰, 孟庆雪, 刘莹. 《2023 AHA/ACC/ACCP/ASPC/NLA/PCNA慢性冠状动脉疾病患者管理指南》要点解读[J]. 中国全科医学, 2024, 27(18): 2173-2178.
[13]	赵慧, 李文豪, 程功, 陈亮, 梁宸源, 王依阳, 蒋红英, 姜瑞嘉. 腺苷负荷与ATP负荷评估冠状动脉微血管疾病中的不良反应分析[J]. 中国全科医学, 2024, 27(17): 2109-2112.
[14]	倪雪桐, 王若羲, 张晶, 杨兴华. 非酒精性脂肪性肝病、代谢相关脂肪性肝病与心血管疾病关联的国内外研究进展[J]. 中国全科医学, 2024, 27(16): 2033-2038.
[15]	曹佳岑, 张宏坤, 赵文, 南月敏, 李冬冬. 血红素氧合酶1调节铁死亡在非酒精性脂肪性肝病中的研究进展[J]. 中国全科医学, 2024, 27(14): 1782-1788.